LTI-214 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,507 results for “LTI-214”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

40 participants · First posted Aug 22, 2017

A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions

44 participants · First posted Nov 12, 2019

Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure

36 participants · First posted Jan 2, 2018

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

24 participants · First posted Jul 20, 2023

Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement

26 participants · First posted Apr 5, 2018

Active, not recruiting

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

20 participants · First posted Oct 19, 2015

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

76 participants · First posted Jul 16, 2013

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

120 participants · First posted May 13, 2025

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

38 participants · First posted Jun 25, 2012

Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects

71 participants · First posted Jan 18, 2020

Page 1 of 174